Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Farmers may struggle to access Defra’s £225m Capital Grants scheme after key advisers warned they are already unable to take on new requests as part of ...

Dairy giant Bega Group has lodged plans for a state-of-the-art cold storage facility in Cairns, creating 32 local jobs in the ...

The upbeat Indonesian state company on its website and social media hailed the Mako contract as marking a strategic foray ...

Scientists have discovered a new quantitative biomarker in lumbar fluid that is helping doctors to diagnose Parkinson's ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...

Children born with a rare neuromuscular disorder are being given another chance in life thanks to a new treatment experts are ...

Neumora Therapeutics is downgraded from 'Strong Buy' to 'Hold' following KOASTAL-1's failure in the MDD primary endpoint.

By Nancy Lapid March 25 (Reuters) - Fake X-ray images created by artificial intelligence to resemble true results from human ...